Evidence map›Paper›PMID 30824597›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Formylglycine-generating enzyme binds substrate directly at a mononuclear Cu(I) center to initiate O

Mason J Appel, Katlyn K Meier, Julien Lafrance-Vanasse, Hyeongtaek Lim, Chi-Lin Tsai, Britt Hedman, Keith O Hodgson, John A Tainer, Edward I Solomon, Carolyn R Bertozzi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Mechanism of OACS central science · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Promiscuous Enzymes for Residue-Specific Peptide and Protein Late-Stage Functionalization.Chembiochem : a European journal of chemical biology · 2023
    Review
  14. Ligand-Copper(I) Primary OAccounts of chemical research · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Mason J AppelDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
Katlyn K MeierDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Julien Lafrance-VanasseMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720.
Hyeongtaek LimDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Chi-Lin TsaiDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Britt HedmanStanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Stanford University, Menlo Park, CA 94025.
Keith O HodgsonDepartment of Chemistry, Stanford University, Stanford, CA 94305.
John A TainerMolecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720; jtainer@mdanderson.org edward.solomon@stanford.edu bertozzi@stanford.edu.
Edward I SolomonDepartment of Chemistry, Stanford University, Stanford, CA 94305; jtainer@mdanderson.org edward.solomon@stanford.edu bertozzi@stanford.edu.ORCID 0000-0003-0291-3199
Carolyn R BertozziDepartment of Chemistry, Stanford University, Stanford, CA 94305; jtainer@mdanderson.org edward.solomon@stanford.edu bertozzi@stanford.edu.ORCID 0000-0003-4482-2754
SLAC National Accelerator Laboratory · USStanford University · USThe University of Texas MD Anderson Cancer Center · USHoward Hughes Medical Institute · USLawrence Berkeley National Laboratory · USUniversity of California, Berkeley · US

Funding

Structure/Function Correlations Over Copper EnzymesR01DK031450 · NIDDK · STANFORD UNIVERSITY · PI EDWARD I SOLOMON · 1986 to 2026
$8.7M
Targeting the Cancer GlycocalyxR01CA227942 · NCI · STANFORD UNIVERSITY · PI Carolyn Bertozzi · 2019 to 2026
$3.6M
Spectroscopic and computational characterization of Cu/O2 species in Cu enzymesF32GM116240 · NIGMS · STANFORD UNIVERSITY · PI MEIER, KATLYN KELLI · 2015 to 2017
$162k
NCI NIH HHS R01 CA227942NIDDK NIH HHS R01 DK031450NIGMS NIH HHS F32 GM116240
6 · The paper itself

Abstract

The formylglycine-generating enzyme (FGE) is required for the posttranslational activation of type I sulfatases by oxidation of an active-site cysteine to C

Indexed as

CatalysisCatalytic DomainCopperCrystallography, X-RayCysteineGlycineOxidation-ReductionOxygenSulfatasesCopperCysteineGlycineN-formylglycineOxygenSulfatasesbioinorganic chemistrycopper oxidaseformylglycinemetalloenzymeX-ray spectroscopy

Identifiers

PMID30824597
PMCPMC6431200
OpenAlexW2920095441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.